Article info

Download PDFPDF

Protocol
Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness

Authors

  1. Correspondence to Dr Kurinchi Gurusamy; k.gurusamy{at}ucl.ac.uk
View Full Text

Citation

Gurusamy K, Vale CL, Pizzo E, et al
Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness

Publication history

  • Received April 14, 2020
  • Revised April 17, 2020
  • Accepted April 20, 2020
  • First published May 12, 2020.
Online issue publication 
May 12, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.